| 发明名称 |
ANTI-CD20 ANTIBODY TREATMENT OF PATIENTS RECEIVING BMT OR PBSC TRANSPLANTS |
| 摘要 |
<p>The use of anti-CD20 antibodies as in vivo purging agents for patients receiving bone marrow or peripheral blood stem cell transplant during treatment of B-cell-related diseases, e.g., B-cell lymphomas or leukemias, is disclosed. Such purging may enhance engraftment and/or prevent disease relapse in such patients.</p> |
| 申请公布号 |
EP1131096(B1) |
申请公布日期 |
2010.01.06 |
| 申请号 |
EP19990958649 |
申请日期 |
1999.11.09 |
| 申请人 |
BIOGEN IDEC INC. |
发明人 |
GRILLO-LOPEZ, ANTONIO, J.;LEONARD, JOHN, E. |
| 分类号 |
A61K39/395;A61K35/02;A61K39/00;A61P35/00;A61P35/02;A61P37/06;C07K16/28 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
